Cargando…
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
Autores principales: | Jawhar, Mohamad, Naumann, Nicole, Knut, Marcin, Score, Joannah, Ghazzawi, Muna, Schneider, Brigitte, Kreuzer, Karl-Anton, Hallek, Michael, Drexler, Hans G, Chacko, Joseph, Wallis, Louise, Fabarius, Alice, Metzgeroth, Georgia, Hofmann, Wolf-Karsten, Chase, Andrew, Tapper, Will, Reiter, Andreas, Cross, Nicholas C.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630086/ https://www.ncbi.nlm.nih.gov/pubmed/28751768 http://dx.doi.org/10.1038/leu.2017.240 |
Ejemplares similares
-
Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins
por: Cibis, Hannah, et al.
Publicado: (2020) -
P1073: MUTATIONAL LANDSCAPE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELOID AND LYMPHOID NEOPLASMS WITH EOSINOPHILIA (MLN-EOS) AND ABNORMALITIES OF PDGFRA, PDGFRB, FGFR1, FLT3 AND JAK REARRANGEMENT
por: Zhang, Y., et al.
Publicado: (2022) -
ZMYM2 inhibits NANOG-mediated reprogramming
por: Lawrence, Moyra, et al.
Publicado: (2019) -
Detection of a PDGFRB fusion in refractory CMML without eosinophilia: A case for broad spectrum tumor profiling
por: Bell, Gillian C., et al.
Publicado: (2015) -
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors
por: Byrgazov, K, et al.
Publicado: (2017)